Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines

  • G. He, O. Andersen, S. B. Haugaard, A. S. Lihn, S. B. Pedersen, S. Madsbad, B. Richelsen
  • European Journal of Clinical Investigation, September 2005, Wiley
  • DOI: 10.1111/j.1365-2362.2005.01547.x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/j.1365-2362.2005.01547.x

The following have contributed to this page: Steen B. Pedersen